© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#COVID-19 treatment

Two scientists cooperating while examining antiviral drug in a test tube at laboratory
FDA Approves Remdesivir for Hospitalized COVID-19 Patients
coronavirus
NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials
Senior patient in hospital bed nurse
How is COVID-19 treated?

New COVID-19 Treatment Advice and Vaccine Guidance for Cancer Patients

Leading cancer and infectious disease experts provide recommendations for both treatment and prevention of COVID-19 for people with cancer.
Fatima Hassan and Gregg Gonsalves call for global COVID-19 vaccine access at CROI 2021 opening plenary

Advocates Call for Global Access to COVID-19 Vaccines

At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

Patients Fend for Themselves to Access Highly Touted COVID Antibody Treatments

Even as drugmakers ramp up supplies, only a trickle of the product has found its way into regular people.
Sea squirt

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants

Plitidepsin, derived from a sea squirt, may be far more potent than remdesivir against the coronavirus.

Full-Dose Blood Thinners Improve Outcomes for Hospitalized COVID-19 Patients

Full-dose anticoagulation treatment for moderately ill COVID-19 patients reduced the need for ventilators.
Novel coronavirus SARS-CoV-2

Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild to Moderate COVID-19

The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.
RNA strand

COVID-19 Vaccine’s mRNA Technology Could One Day Help Treat Cancer

Vaccines that stimulate immune responses against cancer using the mRNA technology may be fast-acting and cheap to make.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Experimental Monoclonal Antibody Not Effective for Hospitalized COVID-19 Patients in Phase III Trial

Bamlanivimab did not speed clinical improvement or reduce the time to hospital discharge or sustained recovery.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Investigational COVID-19 Therapeutics To Be Evaluated in Large Clinical Trials

Two Phase III clinical trials are evaluating monoclonal antibodies for people hospitalized with moderate COVID-19.
Remdesivir production.

Baricitinib Plus Remdesivir Shows Promise for Treating COVID-19

The anti-inflammatory and antiviral drug combination reduced time to recovery for people hospitalized with COVID-19.

No More ICU Beds at the Main Public Hospital in the Nation’s Largest County

In Los Angeles County, daily new COVID cases, deaths and hospitalizations have soared beyond their previous highs.

Lie of the Year: The Downplay and Denial of the Coronavirus

Lies infected America in 2020. The very worst were not just damaging, but deadly.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Agency grants emergency authorization for antibody cocktail given to President Trump.

FDA Authorizes Drug Combination for Treatment of COVID-19

Arthritis drug Olumiant (baricitinib) can be used in combination with remdesivir.
Novel coronavirus SARS-CoV-2

Treatments for People With Early Covid-19 Infection Is an Urgent Research Focus

Effective, early interventions would benefit individual patients and healthcare system.
Advertisement
Ask COVID Health
Features